Schedule 13G ownership disclosure

AMAG PHARMACEUTICALS INC.

Security class unavailable · CUSIP: 00163U106

Event date: 2016-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,063,044
Percent of class
3.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001144204-17-008791
Form type
SC 13G/A
Filer
AMAG PHARMACEUTICALS, INC.
CIK
CIK 792977
Filed
Feb 14, 2017
Reporting period
Dec 31, 2016
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub